4//SEC Filing
AGIOS PHARMACEUTICALS INC 4
Accession 0001209191-15-083759
$AGIOCIK 0001439222operating
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:30 PM ET
Size
5.8 KB
Accession
0001209191-15-083759
Insider Transaction Report
Form 4
Higgons John Duncan
Chief Operating Officer10% Owner
Transactions
- Award
Stock option (right to buy)
2015-12-03+34,090→ 239,112 totalExercise: $9.05Exp: 2023-04-29→ Common stock (34,090 underlying)
Footnotes (1)
- [F1]This option was originally granted on April 30, 2013 for the purchase of 68,181 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to an additional 50% upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of the option as to 34,090 shares. The second performance milestone has not yet been met.
Documents
Issuer
AGIOS PHARMACEUTICALS INC
CIK 0001439222
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001439222
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:30 PM ET
- Size
- 5.8 KB